-
Mashup Score: 3Interview: Owner of Bone & Body Women's Health Dr. Kristi Tough DeSapri talks about Osteoporosis in women - 3 month(s) ago
Updated: Aug. 3, 2023 at 12:28 PM EDTShare on FacebookEmail This LinkShare on X (formerly Twitter)Share on PinterestShare on LinkedIn
Source: www.wtvm.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 5Interview: Owner of Bone & Body Women's Health Dr. Kristi Tough DeSapri talks about Osteoporosis in women - 3 month(s) ago
Updated: Aug. 3, 2023 at 12:28 PM EDTShare on FacebookEmail This LinkShare on X (formerly Twitter)Share on PinterestShare on LinkedIn
Source: www.wtvm.comCategories: General Medicine News, PayerTweet-
“After menopause, your body loses more bone than it creates.” We’ve collaborated with Dr. Kristi Tough who explains that tackling postmenopausal #osteoporosis doesn't have to be a solitary journey. ➡️ Learn more about osteoporosis from Dr. Tough: https://t.co/RPEP1MF9Ld https://t.co/V3NyItIDkx
-
-
Mashup Score: 10
The FDA has added a boxed warning for denosumab to advise patients with advanced chronic kidney disease of an increased risk for severe hypocalcemia, according to an FDA drug safety communication. On Jan. 19, the FDA said it had concluded that denosumab (Prolia, Amgen) increases the risk for severe hypocalcemia for people with advanced CKD, particularly those on dialysis. The announcement came
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet-
🚨The @US_FDA has added a boxed warning for the #osteoporosis medication denosumab, saying there is an increased severe hypocalcemia risk for patients with advanced CKD on dialysis. Read more 👇 @OrthoToday @HealioRheum @Nephronline @healiowomen https://t.co/DfKfBMrUlH
-
-
Mashup Score: 9
The FDA has added a boxed warning for denosumab to advise patients with advanced chronic kidney disease of an increased risk for severe hypocalcemia, according to an FDA drug safety communication. On Jan. 19, the FDA said it had concluded that denosumab (Prolia, Amgen) increases the risk for severe hypocalcemia for people with advanced CKD, particularly those on dialysis. The announcement came
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet-
🚨The @US_FDA has added a boxed warning for the #osteoporosis medication denosumab, saying there is an increased severe hypocalcemia risk for patients with advanced CKD on dialysis. Read more 👇 @OrthoToday @HealioRheum @Nephronline @healiowomen https://t.co/DfKfBMrUlH
-
-
Mashup Score: 2Interview: Owner of Bone & Body Women's Health Dr. Kristi Tough DeSapri talks about Osteoporosis in women - 3 month(s) ago
Updated: Aug. 3, 2023 at 12:28 PM EDTShare on FacebookEmail This LinkShare on X (formerly Twitter)Share on PinterestShare on LinkedIn
Source: www.wtvm.comCategories: General Medicine News, PayerTweet-
“After menopause, your body loses more bone than it creates.” We’ve collaborated with Dr. Kristi Tough who explains that tackling postmenopausal #osteoporosis doesn't have to be a solitary journey. ➡️ Learn more about osteoporosis from Dr. Tough: https://t.co/yfH3lKKPUW https://t.co/GvTZ8aQTSl
-
-
Mashup Score: 4Interview: Owner of Bone & Body Women's Health Dr. Kristi Tough DeSapri talks about Osteoporosis in women - 4 month(s) ago
Updated: Aug. 3, 2023 at 12:28 PM EDTShare on FacebookEmail This LinkShare on X (formerly Twitter)Share on PinterestShare on LinkedIn
Source: www.wtvm.comCategories: General Medicine News, PayerTweet-
“After menopause, your body loses more bone than it creates.” We’ve collaborated with Dr. Kristi Tough who explains that tackling postmenopausal #osteoporosis doesn't have to be a solitary journey. ➡️ Learn more about osteoporosis from Dr. Tough: https://t.co/YJRkLIn92r https://t.co/VW7UEtuiYq
-
-
Mashup Score: 0Polygenic risk score incorporating rare variants does not improve fracture prediction - 5 month(s) ago
The identification of rare genetic variants that influence bone mineral density did not significantly improve fracture risk screening among a large group of adults, according to data published in Journal of Bone and Mineral Research. Using data from the UK Biobank, researchers performed whole-exome sequencing to identify 12 rare genetic variants that influence BMD. However, when those rare
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet-
🦴Including 12 rare genetic variants in a polygenic risk score for predicting #osteoporosis and fractures only slightly improved prediction accuracy when compared with a risk score including only common variants. Read more 👇 @TianyuanLu1 https://t.co/QTxeiaPTNX
-
-
Mashup Score: 4
With so much focus on vitamin D, it’s surprising you don’t hear more about vitamin K2. A number of studies show a link between vitamin K2, bone health and heart health. Is vitamin K2 a nutrient you need more of in your diet? As physicians, we feel everyone needs to be aware of the role this vitam…
Source: www.amazon.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Studies link a higher intake of #vitamin K2 with fewer bone fractures. This vitamin helps direct calcium to the bone and away from the inner walls of arteries where it might contribute to plaque formation. #osteoporosis #health https://t.co/gHfjOcnABB https://t.co/iAMiJo7eNj
-
-
Mashup Score: 0Validating the Fracture Risk Assessment Tool Score in a US Population-Based Study of Patients With Rheumatoid Arthritis - 7 month(s) ago
Objective The World Health Organization fracture risk assessment tool (FRAX) algorithm for risk prediction of major osteoporotic and hip fractures accounts for several risk factors, including rheumatoid arthritis (RA), since individuals with RA have an excess burden of fractures. FRAX has not been validated in population-based RA cohorts in the US. We aimed to determine the accuracy of FRAX predictions for individuals with RA in the US. Methods This retrospective population-based cohort study included residents of Olmsted County, Minnesota, who were followed until death, migration, or last medical record review. Each patient with RA (1987 American College of Rheumatology criteria met in 1980-2007, age 40-89 years) was matched 1:1 on age and sex to an individual without RA from the same underlying population. Ten-year predictions for major osteoporotic and hip fractures were estimated using the FRAX tool. Fractures were ascertained through follow-up, truncated at 10 years. Standardized
Source: www.jrheum.orgCategories: Latest Headlines, RheumatologyTweet-
Research Article Validating the Fracture Risk Assessment Tool Score in a US Population-Based Study of Patients With Rheumatoid Arthritis 📰 https://t.co/AekfCXf4pG #bonemineraldensity #FRAX #osteoporosis #rheumatoidarthritis https://t.co/o0kCTvfo9K
-
-
Mashup Score: 12
Researchers have developed a new high-resolution, analytical technique to identify the rare senescent bone cells that are known to drive […]
Source: discoverysedge.mayo.eduCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
The senescent cells that drive #aging related diseases are notoriously hard to identify —but now Mayo researchers have done just that. They’ve developed a new technique to pinpoint these rare cells in bones, where they can lead to #osteoporosis. https://t.co/9Gy3QBgCrW
-
“After menopause, your body loses more bone than it creates.” We’ve collaborated with Dr. Kristi Tough who explains that tackling postmenopausal #osteoporosis doesn't have to be a solitary journey. ➡️ Learn more about osteoporosis from Dr. Tough: https://t.co/9DjusFbstP https://t.co/PBGnglAfez